Follow the manufacturer label or pharmacy beyond-use date
How cagrilintide works at the cellular level Understanding the mechanism helps you appreciate why cagrilintide produces different effects than GLP-1 agonists like semaglutide
Liposomal formulations, reduced glutathione variants, and alternative delivery routes (IV, intramuscular, nebulized) bypass this limitation but require clinical administration
ThermiSmooth does not require you to take time off from work or social engagements
Occasionally, users experience mild redness at the injection site, lightheadedness, or digestive upset
However, as of now, the FDA has approved GLP-1 drugs only in the form of injections and pills 1 , 2 , and there are no approved form of GLP-1 transdermal (skin) patches which are in medical use